What can we learn from EQAs and audits for cardiac marker testing? Dr P. O. Collinson MA MB BChir FRCPath MD FACB Consultant Chemical Pathologist and Director of Clinical Blood Sciences, Head of Vascular Risk Management, - Left bundle branch block - Document - PDFSEARCH.IO

First Page	Meta Content
	What can we learn from EQAs and audits for cardiac marker testing? Dr P. O. Collinson MA MB BChir FRCPath MD FACB Consultant Chemical Pathologist and Director of Clinical Blood Sciences, Head of Vascular Risk Management, Add to Reading List Document Date: 2014-01-15 11:47:33 Open Document File Size: 2,31 MB Share Result on Facebook Company Vascular Risk Management / MD FACB / / Continent Europe / / Facility Hospital Conflicts / / MedicalCondition cardiac failure / myocardial necrosis / acute myocardial infarction / / Organization Member NICE Diagnostics Advisory Committee / / Person Blood Sciences / Alan Reid / P. O. Collinson / / Position Head / Consultant Chemical Pathologist and Director of Clinical / / SocialTag Biomarkers Medical emergencies Aging-associated diseases Cardiology Myocardial infarction Cardiac marker Left bundle branch block Medicine Chemical pathology Health

What can we learn from EQAs and audits for cardiac marker testing? Dr P. O. Collinson MA MB BChir FRCPath MD FACB Consultant Chemical Pathologist and Director of Clinical Blood Sciences, Head of Vascular Risk Management,Add to Reading List